Log in
Enquire now
‌

US Patent 8354249 Intravenous immunoglobulin composition

Patent 8354249 was granted and assigned to Omrix Biopharmaceuticals on January, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Omrix Biopharmaceuticals
Omrix Biopharmaceuticals
0
Date Filed
August 11, 2005
0
Date of Patent
January 15, 2013
0
Patent Application Number
11201282
0
Patent Citations Received
‌
US Patent 11780906 Compositions and methods for the treatment of immunodeficiency
Patent Inventor Names
Israel Nur
0
Liliana Bar
0
Orgad Laub
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8354249
0
Patent Primary Examiner
‌
Benjamin P Blumel
0

Find more entities like US Patent 8354249 Intravenous immunoglobulin composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.